Cultex Laboratories GmbH

Welcome to one of the world’s leaders in the research and development of cell-based exposure systems and cultivation technologies.

The CULTEX® technology is the platform for the in vitro toxicological analysis of airborne substances, such as gases, particles, volatile compounds and complex gas mixtures at the air-liquid interface to simulate realistic atmospheric conditions (in- and outdoor).

Discover the possibilities of our internationally patented exposure and cultivation systems.

We accept research and development contracts from the industrial as well as the public sector. Our consulting and planning services support both project planning and implementation.

Cultex® Laboratories GmbH was formed in July 2007 by Prof. Dr. med. Drs. h.c. Ulrich Mohr and Prof. Dr. rer. nat. Michaela Aufderheide, to further advance their in vitro activities in the field of inhalation toxicology.
The founders both have outstanding track records in cutting edge research, development and implementation relating to the in vitro analysis of airborne gases, volatile compounds and complex mixtures with a special focus on the simulation of real exposure situations.

Cultex® Laboratories GmbH is able to offer its clients a full service spectrum spanning advice, planning and execution – underpinned by the development of new techniques within in vitro toxicology with special emphasis on inhalation toxicology. The company is headquartered at the Medical Park Hannover/Northern Germany.

Core activities:
Consulting, planning and implementation of contracts for the in vitro toxicology R&D targeting cell culture systems and exposure technologies as well as the technical development of advanced in vitro exposure and cultivation systems, especially for long-term cultures at the air-liquid interface.

Cooperations:
Cultex® Laboratories GmbH is proud to announce a cooperation agreement with Beijing Biolaunching Tech. Co., Ltd for marketing, sales, technical consultation and post-sales support services in China.